Full-Time

Senior Network Engineer

Posted on 8/1/2024

Revolution Medicines

Revolution Medicines

501-1,000 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$155k - $187kAnnually

Senior

San Carlos, CA, USA

Hybrid position requiring in-office presence.

Category
Network Administration
IT & Security
Required Skills
Computer Networking
Requirements
  • 8-10 years of relevant experience.
  • Cisco CCIE Expert certification
  • Experience designing and building complex network environments.
  • Expertise with Azure SD-WAN architecture.
  • Experience with Zscaler ZTNA configurations
  • Expertise with Meraki firewall, switch, and WAP systems.
  • Wide experience in managing and implementing network segmentation and access control across on-prem and cloud networks.
Responsibilities
  • Designing and configuring network infrastructure, including LAN/WAN, routers, switches, firewalls, and VPNs.
  • Maintain, manage, and administer our Azure SDWAN environment.
  • Monitoring network performance and capacity, diagnosing and resolving system issues.
  • Ensuring infrastructure resiliency, including redundancy, configuration backups, DR, and business continuity.
  • Managing network access control and security policies to ensure compliance with organizational and industry standards.
  • Implementing network and server security measures, including firewalls, intrusion detection and prevention systems, and antimalware solutions.
  • Design and build new network architecture in collaboration with security teams to meet security requirements and standards.
  • Managing and troubleshooting network hardware and software, including modems, switches, routers, and other devices.
  • Evaluating and recommending new hardware and software technologies to improve network performance and capabilities.
  • Working with security team to design, build, manage, & troubleshoot Zscaler ZTNA integration with our networking environment.
  • Working cross-functionally in a fast-paced environment to identify future company growth and needs, recommend scalable solutions, and help formulate a technical roadmap for the company.
  • Documenting system configurations, processes, and procedures to maintain system integrity and support knowledge transfer.
  • Providing escalated technical support to end-users, including troubleshooting issues related to network and providing guidance on best practices and policies.
  • Collaborating with other IS teams and departments to ensure alignment of IT solutions with organizational objectives and standards.
  • Managing projects within budget requirements
  • Ensuring network and server infrastructure meets compliance requirements, including SOX audits and GxP system qualification, validation, & risk assessments.
  • Help team with other non-network projects, tasks, and troubleshooting as needed.

Revolution Medicines develops targeted treatments for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to inhibit the activity of RAS proteins that promote cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses specifically on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-3%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EQRx adds over $1 billion in capital for R&D.
  • FDA fast-tracking supports their RAS-targeted therapy pipeline.
  • Growing interest in targeted cancer therapies boosts investment opportunities.

What critics are saying

  • EQRx acquisition may pose integration challenges and cultural clashes.
  • $600M public stock offering could lead to shareholder dilution.
  • Focus on RAS-addicted cancers limits market scope and increases competition risk.

What makes Revolution Medicines unique

  • Revolution Medicines reconfigures natural substances into best-in-class cancer therapies.
  • Their Tri Complex Inhibitor platform targets RAS proteins driving cancer growth.
  • Exclusive license with University of Illinois enhances their unique synthesis technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

INACTIVE